Single‐cell and bulk RNA‐sequencing reveals mitosis‐involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD)
Cell Biology International · 2024
DOI: 10.1002/cbin.12191 ↗At a glance
Journal article in Cell Biology International, 2024. Written by Shiwei Liu and 4 co-authors. Institution: Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Major MEDLINE topics: Adenocarcinoma, Mitosis, Prostatic Neoplasms, Sequence Analysis, RNA. Cited 3 times so far (Crossref); 47 references.
Abstract (original language)
It was imperative to identify latent biomarkers pertinent to malignancies, given the pivotal role targeted molecular therapies play in tumor treatment investigations. This study aimed to assess the validity of HAUS1 as an indicator for survival prognosis and immune responses in prostate adenocarcinoma (PRAD) via single‐cell and bulk RNA‐sequencing. Related data on HAUS1 expression in PRAD were obtained from online databases, followed by comprehensive analyses to delineate its associations with survival prognosis, implicated pathways, and immune responses. Besides, the expression pattern of HAUS1 in PRAD was also verified in vitro, by using qRT‐PCR, Western blot analysis, and immunohistochemistry. We found HAUS1 was downregulated in PRAD compared with normal tissues, as verified in vitro by qRT‐PCR, Western blot, and immunohistochemistry ( p < 0.05). Single‐cell RNA‐sequencing analysis indicated that HAUS1 had relatively higher expressions in B cells, Mono/Macro cells, and Endothelial cells compared with other cell types. Cox regression analysis revealed HAUS1 could serve as an independent indicator for the overall survival prognosis of PRAD ( p < 0.05). Spearman correlation analyses revealed HAUS1 was closely related to the tumor microenvironment, immune cell infiltration levels, immune checkpoints, and immune cell pathways ( p < 0.05). Furthermore, HAUS1 expression was found to be closely related to the immunotherapeutic response of patients receiving clinical intervention ( p < 0.05). Collectively, our findings underscored the significant role of HAUS1 in PRAD prognosis and immune response, thereby presenting a novel and promising avenue for investigating the clinical utility of immunotherapy in PRAD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Nursing Department, Wujiang Fifth People's Hospital, Suzhou, China.
- Department of Urology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.
Cite
APA
Liu, S., Yu, Y., Xu, J., Wang, Y., & Li, D. (2024). Single‐cell and bulk RNA‐sequencing reveals mitosis‐involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD). Cell Biology International. https://doi.org/10.1002/cbin.12191
Vancouver
Liu S, Yu Y, Xu J, Wang Y, Li D. Single‐cell and bulk RNA‐sequencing reveals mitosis‐involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD). Cell Biology International. 2024. doi:10.1002/cbin.12191
BibTeX
@article{Liu2024,
author = {Liu, Shiwei and Yu, Yang and Xu, Jie and Wang, Yi and Li, Deng},
title = {Single‐cell and bulk RNA‐sequencing reveals mitosis‐involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD)},
journal = {Cell Biology International},
year = {2024},
doi = {10.1002/cbin.12191}
}
EUVIMED